nodes	percent_of_prediction	percent_of_DWPC	metapath
Clomipramine—HRH2—coronary artery disease	0.209	0.523	CbGaD
Clomipramine—GSTP1—coronary artery disease	0.0866	0.217	CbGaD
Clomipramine—CYP2C19—coronary artery disease	0.044	0.11	CbGaD
Clomipramine—HTR2A—coronary artery disease	0.0357	0.0894	CbGaD
Clomipramine—ALB—coronary artery disease	0.0244	0.0611	CbGaD
Clomipramine—ALB—Pitavastatin—coronary artery disease	0.0132	0.038	CbGbCtD
Clomipramine—ALB—Valsartan—coronary artery disease	0.0128	0.037	CbGbCtD
Clomipramine—ABCB1—Ticagrelor—coronary artery disease	0.0127	0.0368	CbGbCtD
Clomipramine—CYP2C19—Gemfibrozil—coronary artery disease	0.0113	0.0325	CbGbCtD
Clomipramine—CYP1A2—Gemfibrozil—coronary artery disease	0.0104	0.03	CbGbCtD
Clomipramine—CYP2C19—Clopidogrel—coronary artery disease	0.00976	0.0282	CbGbCtD
Clomipramine—ALB—Rosuvastatin—coronary artery disease	0.0097	0.028	CbGbCtD
Clomipramine—ALB—Acetylsalicylic acid—coronary artery disease	0.00946	0.0273	CbGbCtD
Clomipramine—ALB—Captopril—coronary artery disease	0.00934	0.027	CbGbCtD
Clomipramine—CYP1A2—Clopidogrel—coronary artery disease	0.00901	0.026	CbGbCtD
Clomipramine—CYP2C19—Telmisartan—coronary artery disease	0.00853	0.0247	CbGbCtD
Clomipramine—ABCB1—Perindopril—coronary artery disease	0.00788	0.0228	CbGbCtD
Clomipramine—ABCB1—Clopidogrel—coronary artery disease	0.00788	0.0228	CbGbCtD
Clomipramine—CYP3A4—Ticagrelor—coronary artery disease	0.00764	0.0221	CbGbCtD
Clomipramine—ALB—Furosemide—coronary artery disease	0.00751	0.0217	CbGbCtD
Clomipramine—ALB—Losartan—coronary artery disease	0.00735	0.0213	CbGbCtD
Clomipramine—ABCB1—Pitavastatin—coronary artery disease	0.00688	0.0199	CbGbCtD
Clomipramine—ABCB1—Telmisartan—coronary artery disease	0.00688	0.0199	CbGbCtD
Clomipramine—CYP2C19—Timolol—coronary artery disease	0.00688	0.0199	CbGbCtD
Clomipramine—CYP3A4—Fenofibrate—coronary artery disease	0.00681	0.0197	CbGbCtD
Clomipramine—ABCB1—Enalapril—coronary artery disease	0.00653	0.0189	CbGbCtD
Clomipramine—ABCB1—Lisinopril—coronary artery disease	0.00653	0.0189	CbGbCtD
Clomipramine—CYP2C19—Rosuvastatin—coronary artery disease	0.00629	0.0182	CbGbCtD
Clomipramine—HTR2B—cardial valve—coronary artery disease	0.00622	0.229	CbGeAlD
Clomipramine—CYP2C19—Acetylsalicylic acid—coronary artery disease	0.00613	0.0177	CbGbCtD
Clomipramine—CYP2C19—Simvastatin—coronary artery disease	0.00585	0.0169	CbGbCtD
Clomipramine—CYP2C19—Lovastatin—coronary artery disease	0.00572	0.0165	CbGbCtD
Clomipramine—CYP2D6—Niacin—coronary artery disease	0.00562	0.0163	CbGbCtD
Clomipramine—ABCB1—Timolol—coronary artery disease	0.00555	0.016	CbGbCtD
Clomipramine—CYP3A4—Gemfibrozil—coronary artery disease	0.00544	0.0157	CbGbCtD
Clomipramine—CYP2D6—Timolol—coronary artery disease	0.00523	0.0151	CbGbCtD
Clomipramine—CYP2C19—Atorvastatin—coronary artery disease	0.00521	0.0151	CbGbCtD
Clomipramine—ABCB1—Ezetimibe—coronary artery disease	0.00508	0.0147	CbGbCtD
Clomipramine—ABCB1—Acetylsalicylic acid—coronary artery disease	0.00495	0.0143	CbGbCtD
Clomipramine—ABCB1—Captopril—coronary artery disease	0.00489	0.0141	CbGbCtD
Clomipramine—CYP2C19—Losartan—coronary artery disease	0.00477	0.0138	CbGbCtD
Clomipramine—CYP3A4—Clopidogrel—coronary artery disease	0.00472	0.0136	CbGbCtD
Clomipramine—ABCB1—Simvastatin—coronary artery disease	0.00472	0.0136	CbGbCtD
Clomipramine—ABCB1—Lovastatin—coronary artery disease	0.00462	0.0133	CbGbCtD
Clomipramine—ABCB1—Pravastatin—coronary artery disease	0.00462	0.0133	CbGbCtD
Clomipramine—CYP2D6—Captopril—coronary artery disease	0.0046	0.0133	CbGbCtD
Clomipramine—CYP2D6—Simvastatin—coronary artery disease	0.00445	0.0129	CbGbCtD
Clomipramine—CYP1A2—Losartan—coronary artery disease	0.0044	0.0127	CbGbCtD
Clomipramine—CYP3A4—Eplerenone—coronary artery disease	0.00439	0.0127	CbGbCtD
Clomipramine—CYP2D6—Lovastatin—coronary artery disease	0.00435	0.0126	CbGbCtD
Clomipramine—CYP2D6—Pravastatin—coronary artery disease	0.00435	0.0126	CbGbCtD
Clomipramine—ABCB1—Atorvastatin—coronary artery disease	0.00421	0.0122	CbGbCtD
Clomipramine—CYP2D6—Atorvastatin—coronary artery disease	0.00396	0.0115	CbGbCtD
Clomipramine—CYP3A4—Enalapril—coronary artery disease	0.00391	0.0113	CbGbCtD
Clomipramine—ABCB1—Losartan—coronary artery disease	0.00385	0.0111	CbGbCtD
Clomipramine—CYP3A4—Rosuvastatin—coronary artery disease	0.00304	0.00879	CbGbCtD
Clomipramine—CYP3A4—Ezetimibe—coronary artery disease	0.00304	0.00879	CbGbCtD
Clomipramine—CYP3A4—Simvastatin—coronary artery disease	0.00283	0.00817	CbGbCtD
Clomipramine—CYP3A4—Pravastatin—coronary artery disease	0.00277	0.008	CbGbCtD
Clomipramine—CYP3A4—Lovastatin—coronary artery disease	0.00277	0.008	CbGbCtD
Clomipramine—CYP3A4—Atorvastatin—coronary artery disease	0.00252	0.00728	CbGbCtD
Clomipramine—CYP3A4—Losartan—coronary artery disease	0.0023	0.00666	CbGbCtD
Clomipramine—SLC6A2—sympathetic nervous system—coronary artery disease	0.00217	0.0801	CbGeAlD
Clomipramine—HTR2A—arteriole—coronary artery disease	0.00205	0.0755	CbGeAlD
Clomipramine—SLC6A2—autonomic nervous system—coronary artery disease	0.00146	0.0538	CbGeAlD
Clomipramine—HTR2A—pulmonary artery—coronary artery disease	0.00134	0.0495	CbGeAlD
Clomipramine—HTR2A—sympathetic nervous system—coronary artery disease	0.00131	0.0481	CbGeAlD
Clomipramine—HTR2A—vagus nerve—coronary artery disease	0.00127	0.0466	CbGeAlD
Clomipramine—HTR2A—vein—coronary artery disease	0.00122	0.045	CbGeAlD
Clomipramine—HTR2A—autonomic nervous system—coronary artery disease	0.000878	0.0323	CbGeAlD
Clomipramine—GSTP1—cardiac ventricle—coronary artery disease	0.000635	0.0234	CbGeAlD
Clomipramine—GSTP1—myocardium—coronary artery disease	0.000597	0.022	CbGeAlD
Clomipramine—HRH2—heart—coronary artery disease	0.000579	0.0213	CbGeAlD
Clomipramine—HRH2—cardiovascular system—coronary artery disease	0.000546	0.0201	CbGeAlD
Clomipramine—HTR2A—artery—coronary artery disease	0.000498	0.0183	CbGeAlD
Clomipramine—HRH2—cardiac atrium—coronary artery disease	0.000495	0.0182	CbGeAlD
Clomipramine—HRH2—blood—coronary artery disease	0.000432	0.0159	CbGeAlD
Clomipramine—Olopatadine—S100B—coronary artery disease	0.000428	0.178	CrCbGaD
Clomipramine—HTR2A—endothelium—coronary artery disease	0.000421	0.0155	CbGeAlD
Clomipramine—GSTP1—heart—coronary artery disease	0.000417	0.0153	CbGeAlD
Clomipramine—GSTP1—cardiovascular system—coronary artery disease	0.000393	0.0145	CbGeAlD
Clomipramine—ALB—heart—coronary artery disease	0.000357	0.0131	CbGeAlD
Clomipramine—GSTP1—cardiac atrium—coronary artery disease	0.000356	0.0131	CbGeAlD
Clomipramine—HTR2B—heart—coronary artery disease	0.000344	0.0126	CbGeAlD
Clomipramine—HTR2B—cardiovascular system—coronary artery disease	0.000324	0.0119	CbGeAlD
Clomipramine—GSTP1—blood—coronary artery disease	0.000311	0.0114	CbGeAlD
Clomipramine—SLC6A4—blood—coronary artery disease	0.000259	0.00953	CbGeAlD
Clomipramine—HTR2B—blood—coronary artery disease	0.000256	0.00944	CbGeAlD
Clomipramine—ADRA2A—heart—coronary artery disease	0.000216	0.00794	CbGeAlD
Clomipramine—CYP2C19—blood—coronary artery disease	0.000214	0.00789	CbGeAlD
Clomipramine—ADRA2A—cardiac atrium—coronary artery disease	0.000185	0.00679	CbGeAlD
Clomipramine—HTR2A—heart—coronary artery disease	0.000183	0.00675	CbGeAlD
Clomipramine—CYP1A2—blood—coronary artery disease	0.000175	0.00645	CbGeAlD
Clomipramine—HTR2A—cardiovascular system—coronary artery disease	0.000173	0.00637	CbGeAlD
Clomipramine—ADRA2A—blood—coronary artery disease	0.000161	0.00593	CbGeAlD
Clomipramine—Doxepin—HRH2—coronary artery disease	0.000153	0.0637	CrCbGaD
Clomipramine—HTR2A—blood—coronary artery disease	0.000137	0.00504	CbGeAlD
Clomipramine—CYP3A4—blood—coronary artery disease	0.000127	0.00467	CbGeAlD
Clomipramine—CYP2D6—blood—coronary artery disease	0.000125	0.00459	CbGeAlD
Clomipramine—ABCB1—heart—coronary artery disease	0.00012	0.00443	CbGeAlD
Clomipramine—Amitriptyline—HRH2—coronary artery disease	0.000118	0.0493	CrCbGaD
Clomipramine—ABCB1—cardiovascular system—coronary artery disease	0.000113	0.00418	CbGeAlD
Clomipramine—ABCB1—blood—coronary artery disease	8.97e-05	0.0033	CbGeAlD
Clomipramine—Desipramine—SLC22A3—coronary artery disease	7.53e-05	0.0313	CrCbGaD
Clomipramine—Imipramine—SLC22A3—coronary artery disease	6.38e-05	0.0266	CrCbGaD
Clomipramine—Amitriptyline—OPRD1—coronary artery disease	6.25e-05	0.026	CrCbGaD
Clomipramine—Cyamemazine—HTR2A—coronary artery disease	6.12e-05	0.0255	CrCbGaD
Clomipramine—Carbinoxamine—CYP2C19—coronary artery disease	5.77e-05	0.024	CrCbGaD
Clomipramine—Thioridazine—HTR7—coronary artery disease	5.6e-05	0.0233	CrCbGaD
Clomipramine—Perphenazine—HTR7—coronary artery disease	5.14e-05	0.0214	CrCbGaD
Clomipramine—Clobazam—CYP2C19—coronary artery disease	4.66e-05	0.0194	CrCbGaD
Clomipramine—Pipotiazine—CYP2C19—coronary artery disease	4.66e-05	0.0194	CrCbGaD
Clomipramine—Desipramine—ADRB1—coronary artery disease	4.1e-05	0.017	CrCbGaD
Clomipramine—Chlorpromazine—HTR7—coronary artery disease	4.08e-05	0.017	CrCbGaD
Clomipramine—Imipramine—HTR7—coronary artery disease	4.05e-05	0.0169	CrCbGaD
Clomipramine—Amitriptyline—HTR7—coronary artery disease	4.03e-05	0.0168	CrCbGaD
Clomipramine—Acepromazine—HTR2A—coronary artery disease	3.93e-05	0.0164	CrCbGaD
Clomipramine—Thioproperazine—HTR2A—coronary artery disease	3.84e-05	0.016	CrCbGaD
Clomipramine—Adinazolam—CYP2C19—coronary artery disease	3.8e-05	0.0158	CrCbGaD
Clomipramine—Pipotiazine—HTR2A—coronary artery disease	3.78e-05	0.0157	CrCbGaD
Clomipramine—Nortriptyline—CYP2C19—coronary artery disease	3.6e-05	0.015	CrCbGaD
Clomipramine—Thioridazine—CYP2C19—coronary artery disease	3.47e-05	0.0144	CrCbGaD
Clomipramine—Desipramine—ADRB2—coronary artery disease	3.44e-05	0.0143	CrCbGaD
Clomipramine—Trimipramine—CYP2C19—coronary artery disease	3.39e-05	0.0141	CrCbGaD
Clomipramine—Doxepin—CYP2C19—coronary artery disease	3.23e-05	0.0134	CrCbGaD
Clomipramine—Perphenazine—CYP2C19—coronary artery disease	3.19e-05	0.0133	CrCbGaD
Clomipramine—Propiomazine—HTR2A—coronary artery disease	3.14e-05	0.0131	CrCbGaD
Clomipramine—Chlorprothixene—HTR2A—coronary artery disease	2.97e-05	0.0124	CrCbGaD
Clomipramine—Desipramine—CYP2C19—coronary artery disease	2.96e-05	0.0123	CrCbGaD
Clomipramine—Nortriptyline—HTR2A—coronary artery disease	2.92e-05	0.0121	CrCbGaD
Clomipramine—Promazine—CYP2C19—coronary artery disease	2.87e-05	0.012	CrCbGaD
Clomipramine—Thioridazine—HTR2A—coronary artery disease	2.81e-05	0.0117	CrCbGaD
Clomipramine—Trimipramine—HTR2A—coronary artery disease	2.75e-05	0.0114	CrCbGaD
Clomipramine—Diazepam—CYP2C19—coronary artery disease	2.72e-05	0.0113	CrCbGaD
Clomipramine—Acepromazine—ALB—coronary artery disease	2.69e-05	0.0112	CrCbGaD
Clomipramine—Methotrimeprazine—HTR2A—coronary artery disease	2.69e-05	0.0112	CrCbGaD
Clomipramine—Promethazine—HTR2A—coronary artery disease	2.65e-05	0.011	CrCbGaD
Clomipramine—Thioproperazine—ALB—coronary artery disease	2.63e-05	0.0109	CrCbGaD
Clomipramine—Doxepin—HTR2A—coronary artery disease	2.62e-05	0.0109	CrCbGaD
Clomipramine—Fatigue—Losartan—coronary artery disease	2.61e-05	0.000181	CcSEcCtD
Clomipramine—Trifluoperazine—HTR2A—coronary artery disease	2.61e-05	0.0109	CrCbGaD
Clomipramine—Headache—Ezetimibe—coronary artery disease	2.61e-05	0.000181	CcSEcCtD
Clomipramine—Malaise—Lisinopril—coronary artery disease	2.61e-05	0.000181	CcSEcCtD
Clomipramine—Oedema—Ramipril—coronary artery disease	2.6e-05	0.00018	CcSEcCtD
Clomipramine—Anaphylactic shock—Ramipril—coronary artery disease	2.6e-05	0.00018	CcSEcCtD
Clomipramine—Vertigo—Lisinopril—coronary artery disease	2.6e-05	0.00018	CcSEcCtD
Clomipramine—Dry mouth—Timolol—coronary artery disease	2.59e-05	0.00018	CcSEcCtD
Clomipramine—Constipation—Losartan—coronary artery disease	2.59e-05	0.00018	CcSEcCtD
Clomipramine—Pain—Losartan—coronary artery disease	2.59e-05	0.00018	CcSEcCtD
Clomipramine—Syncope—Lisinopril—coronary artery disease	2.59e-05	0.00018	CcSEcCtD
Clomipramine—Vomiting—Eplerenone—coronary artery disease	2.59e-05	0.00018	CcSEcCtD
Clomipramine—Feeling abnormal—Furosemide—coronary artery disease	2.59e-05	0.00018	CcSEcCtD
Clomipramine—Leukopenia—Lisinopril—coronary artery disease	2.59e-05	0.000179	CcSEcCtD
Clomipramine—Pipotiazine—ALB—coronary artery disease	2.59e-05	0.0108	CrCbGaD
Clomipramine—Perphenazine—HTR2A—coronary artery disease	2.58e-05	0.0107	CrCbGaD
Clomipramine—Nausea—Fenofibrate—coronary artery disease	2.58e-05	0.000179	CcSEcCtD
Clomipramine—Pruritus—Niacin—coronary artery disease	2.58e-05	0.000179	CcSEcCtD
Clomipramine—Asthenia—Pravastatin—coronary artery disease	2.58e-05	0.000179	CcSEcCtD
Clomipramine—Gastrointestinal pain—Furosemide—coronary artery disease	2.57e-05	0.000178	CcSEcCtD
Clomipramine—Rash—Eplerenone—coronary artery disease	2.57e-05	0.000178	CcSEcCtD
Clomipramine—Urticaria—Perindopril—coronary artery disease	2.57e-05	0.000178	CcSEcCtD
Clomipramine—Hypersensitivity—Trandolapril—coronary artery disease	2.57e-05	0.000178	CcSEcCtD
Clomipramine—Dermatitis—Eplerenone—coronary artery disease	2.57e-05	0.000178	CcSEcCtD
Clomipramine—Diarrhoea—Valsartan—coronary artery disease	2.57e-05	0.000178	CcSEcCtD
Clomipramine—Confusional state—Timolol—coronary artery disease	2.56e-05	0.000178	CcSEcCtD
Clomipramine—Shock—Ramipril—coronary artery disease	2.56e-05	0.000177	CcSEcCtD
Clomipramine—Hypersensitivity—Enalapril—coronary artery disease	2.56e-05	0.000177	CcSEcCtD
Clomipramine—Body temperature increased—Perindopril—coronary artery disease	2.56e-05	0.000177	CcSEcCtD
Clomipramine—Abdominal pain—Perindopril—coronary artery disease	2.56e-05	0.000177	CcSEcCtD
Clomipramine—Palpitations—Lisinopril—coronary artery disease	2.55e-05	0.000177	CcSEcCtD
Clomipramine—Diarrhoea—Olmesartan—coronary artery disease	2.55e-05	0.000177	CcSEcCtD
Clomipramine—Headache—Eplerenone—coronary artery disease	2.55e-05	0.000177	CcSEcCtD
Clomipramine—Nervous system disorder—Ramipril—coronary artery disease	2.55e-05	0.000177	CcSEcCtD
Clomipramine—Thrombocytopenia—Ramipril—coronary artery disease	2.55e-05	0.000177	CcSEcCtD
Clomipramine—Oedema—Timolol—coronary artery disease	2.54e-05	0.000176	CcSEcCtD
Clomipramine—Anaphylactic shock—Timolol—coronary artery disease	2.54e-05	0.000176	CcSEcCtD
Clomipramine—Pruritus—Pravastatin—coronary artery disease	2.54e-05	0.000176	CcSEcCtD
Clomipramine—Loss of consciousness—Lisinopril—coronary artery disease	2.54e-05	0.000176	CcSEcCtD
Clomipramine—Nausea—Clopidogrel—coronary artery disease	2.54e-05	0.000176	CcSEcCtD
Clomipramine—Tachycardia—Ramipril—coronary artery disease	2.54e-05	0.000176	CcSEcCtD
Clomipramine—Skin disorder—Ramipril—coronary artery disease	2.53e-05	0.000175	CcSEcCtD
Clomipramine—Vomiting—Simvastatin—coronary artery disease	2.52e-05	0.000175	CcSEcCtD
Clomipramine—Hypersensitivity—Telmisartan—coronary artery disease	2.52e-05	0.000175	CcSEcCtD
Clomipramine—Cough—Lisinopril—coronary artery disease	2.52e-05	0.000175	CcSEcCtD
Clomipramine—Nausea—Lovastatin—coronary artery disease	2.52e-05	0.000175	CcSEcCtD
Clomipramine—Imipramine—CYP2C19—coronary artery disease	2.51e-05	0.0105	CrCbGaD
Clomipramine—Hyperhidrosis—Ramipril—coronary artery disease	2.51e-05	0.000174	CcSEcCtD
Clomipramine—Rash—Simvastatin—coronary artery disease	2.5e-05	0.000174	CcSEcCtD
Clomipramine—Dermatitis—Simvastatin—coronary artery disease	2.5e-05	0.000173	CcSEcCtD
Clomipramine—Asthenia—Trandolapril—coronary artery disease	2.5e-05	0.000173	CcSEcCtD
Clomipramine—Shock—Timolol—coronary artery disease	2.5e-05	0.000173	CcSEcCtD
Clomipramine—Feeling abnormal—Losartan—coronary artery disease	2.5e-05	0.000173	CcSEcCtD
Clomipramine—Amitriptyline—CYP2C19—coronary artery disease	2.5e-05	0.0104	CrCbGaD
Clomipramine—Urticaria—Furosemide—coronary artery disease	2.5e-05	0.000173	CcSEcCtD
Clomipramine—Diarrhoea—Niacin—coronary artery disease	2.49e-05	0.000173	CcSEcCtD
Clomipramine—Nervous system disorder—Timolol—coronary artery disease	2.49e-05	0.000173	CcSEcCtD
Clomipramine—Asthenia—Enalapril—coronary artery disease	2.49e-05	0.000173	CcSEcCtD
Clomipramine—Headache—Simvastatin—coronary artery disease	2.49e-05	0.000172	CcSEcCtD
Clomipramine—Abdominal pain—Furosemide—coronary artery disease	2.48e-05	0.000172	CcSEcCtD
Clomipramine—Body temperature increased—Furosemide—coronary artery disease	2.48e-05	0.000172	CcSEcCtD
Clomipramine—Gastrointestinal pain—Losartan—coronary artery disease	2.48e-05	0.000172	CcSEcCtD
Clomipramine—Dizziness—Valsartan—coronary artery disease	2.48e-05	0.000172	CcSEcCtD
Clomipramine—Anorexia—Ramipril—coronary artery disease	2.48e-05	0.000172	CcSEcCtD
Clomipramine—Nausea—Ezetimibe—coronary artery disease	2.47e-05	0.000172	CcSEcCtD
Clomipramine—Skin disorder—Timolol—coronary artery disease	2.47e-05	0.000171	CcSEcCtD
Clomipramine—Dizziness—Olmesartan—coronary artery disease	2.47e-05	0.000171	CcSEcCtD
Clomipramine—Pruritus—Trandolapril—coronary artery disease	2.47e-05	0.000171	CcSEcCtD
Clomipramine—Myalgia—Lisinopril—coronary artery disease	2.46e-05	0.000171	CcSEcCtD
Clomipramine—Arthralgia—Lisinopril—coronary artery disease	2.46e-05	0.000171	CcSEcCtD
Clomipramine—Chest pain—Lisinopril—coronary artery disease	2.46e-05	0.000171	CcSEcCtD
Clomipramine—Hyperhidrosis—Timolol—coronary artery disease	2.46e-05	0.00017	CcSEcCtD
Clomipramine—Asthenia—Telmisartan—coronary artery disease	2.46e-05	0.00017	CcSEcCtD
Clomipramine—Pruritus—Enalapril—coronary artery disease	2.46e-05	0.00017	CcSEcCtD
Clomipramine—Diarrhoea—Pravastatin—coronary artery disease	2.46e-05	0.00017	CcSEcCtD
Clomipramine—Anxiety—Lisinopril—coronary artery disease	2.45e-05	0.00017	CcSEcCtD
Clomipramine—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—coronary artery disease	2.44e-05	0.000169	CcSEcCtD
Clomipramine—Discomfort—Lisinopril—coronary artery disease	2.43e-05	0.000169	CcSEcCtD
Clomipramine—Hypotension—Ramipril—coronary artery disease	2.43e-05	0.000169	CcSEcCtD
Clomipramine—Anorexia—Timolol—coronary artery disease	2.42e-05	0.000168	CcSEcCtD
Clomipramine—Pruritus—Telmisartan—coronary artery disease	2.42e-05	0.000168	CcSEcCtD
Clomipramine—Nausea—Eplerenone—coronary artery disease	2.42e-05	0.000168	CcSEcCtD
Clomipramine—Dizziness—Niacin—coronary artery disease	2.41e-05	0.000167	CcSEcCtD
Clomipramine—Urticaria—Losartan—coronary artery disease	2.41e-05	0.000167	CcSEcCtD
Clomipramine—Dry mouth—Lisinopril—coronary artery disease	2.41e-05	0.000167	CcSEcCtD
Clomipramine—Desipramine—HTR2A—coronary artery disease	2.4e-05	0.01	CrCbGaD
Clomipramine—Abdominal pain—Losartan—coronary artery disease	2.4e-05	0.000166	CcSEcCtD
Clomipramine—Body temperature increased—Losartan—coronary artery disease	2.4e-05	0.000166	CcSEcCtD
Clomipramine—Asthenia—Captopril—coronary artery disease	2.39e-05	0.000166	CcSEcCtD
Clomipramine—Diarrhoea—Trandolapril—coronary artery disease	2.39e-05	0.000165	CcSEcCtD
Clomipramine—Vomiting—Valsartan—coronary artery disease	2.38e-05	0.000165	CcSEcCtD
Clomipramine—Confusional state—Lisinopril—coronary artery disease	2.38e-05	0.000165	CcSEcCtD
Clomipramine—Diarrhoea—Enalapril—coronary artery disease	2.38e-05	0.000165	CcSEcCtD
Clomipramine—Hypotension—Timolol—coronary artery disease	2.38e-05	0.000165	CcSEcCtD
Clomipramine—Dizziness—Pravastatin—coronary artery disease	2.37e-05	0.000165	CcSEcCtD
Clomipramine—Vomiting—Olmesartan—coronary artery disease	2.37e-05	0.000165	CcSEcCtD
Clomipramine—Musculoskeletal discomfort—Ramipril—coronary artery disease	2.37e-05	0.000164	CcSEcCtD
Clomipramine—Rash—Valsartan—coronary artery disease	2.36e-05	0.000164	CcSEcCtD
Clomipramine—Dermatitis—Valsartan—coronary artery disease	2.36e-05	0.000164	CcSEcCtD
Clomipramine—Nausea—Simvastatin—coronary artery disease	2.36e-05	0.000164	CcSEcCtD
Clomipramine—Oedema—Lisinopril—coronary artery disease	2.36e-05	0.000164	CcSEcCtD
Clomipramine—Anaphylactic shock—Lisinopril—coronary artery disease	2.36e-05	0.000164	CcSEcCtD
Clomipramine—Pruritus—Captopril—coronary artery disease	2.36e-05	0.000163	CcSEcCtD
Clomipramine—Rash—Olmesartan—coronary artery disease	2.35e-05	0.000163	CcSEcCtD
Clomipramine—Insomnia—Ramipril—coronary artery disease	2.35e-05	0.000163	CcSEcCtD
Clomipramine—Dermatitis—Olmesartan—coronary artery disease	2.35e-05	0.000163	CcSEcCtD
Clomipramine—Headache—Valsartan—coronary artery disease	2.35e-05	0.000163	CcSEcCtD
Clomipramine—Diarrhoea—Telmisartan—coronary artery disease	2.34e-05	0.000162	CcSEcCtD
Clomipramine—Headache—Olmesartan—coronary artery disease	2.34e-05	0.000162	CcSEcCtD
Clomipramine—Paraesthesia—Ramipril—coronary artery disease	2.33e-05	0.000162	CcSEcCtD
Clomipramine—Promazine—HTR2A—coronary artery disease	2.33e-05	0.00969	CrCbGaD
Clomipramine—Shock—Lisinopril—coronary artery disease	2.32e-05	0.000161	CcSEcCtD
Clomipramine—Asthenia—Perindopril—coronary artery disease	2.32e-05	0.000161	CcSEcCtD
Clomipramine—Dyspnoea—Ramipril—coronary artery disease	2.32e-05	0.000161	CcSEcCtD
Clomipramine—Vomiting—Niacin—coronary artery disease	2.32e-05	0.000161	CcSEcCtD
Clomipramine—Musculoskeletal discomfort—Timolol—coronary artery disease	2.32e-05	0.000161	CcSEcCtD
Clomipramine—Hypersensitivity—Furosemide—coronary artery disease	2.32e-05	0.000161	CcSEcCtD
Clomipramine—Somnolence—Ramipril—coronary artery disease	2.31e-05	0.00016	CcSEcCtD
Clomipramine—Thrombocytopenia—Lisinopril—coronary artery disease	2.31e-05	0.00016	CcSEcCtD
Clomipramine—Dizziness—Trandolapril—coronary artery disease	2.31e-05	0.00016	CcSEcCtD
Clomipramine—Tachycardia—Lisinopril—coronary artery disease	2.3e-05	0.00016	CcSEcCtD
Clomipramine—Insomnia—Timolol—coronary artery disease	2.3e-05	0.000159	CcSEcCtD
Clomipramine—Rash—Niacin—coronary artery disease	2.3e-05	0.000159	CcSEcCtD
Clomipramine—Dermatitis—Niacin—coronary artery disease	2.3e-05	0.000159	CcSEcCtD
Clomipramine—Dizziness—Enalapril—coronary artery disease	2.3e-05	0.000159	CcSEcCtD
Clomipramine—Skin disorder—Lisinopril—coronary artery disease	2.29e-05	0.000159	CcSEcCtD
Clomipramine—Dyspepsia—Ramipril—coronary artery disease	2.29e-05	0.000159	CcSEcCtD
Clomipramine—Pruritus—Perindopril—coronary artery disease	2.29e-05	0.000159	CcSEcCtD
Clomipramine—Headache—Niacin—coronary artery disease	2.28e-05	0.000158	CcSEcCtD
Clomipramine—Paraesthesia—Timolol—coronary artery disease	2.28e-05	0.000158	CcSEcCtD
Clomipramine—Vomiting—Pravastatin—coronary artery disease	2.28e-05	0.000158	CcSEcCtD
Clomipramine—Hyperhidrosis—Lisinopril—coronary artery disease	2.28e-05	0.000158	CcSEcCtD
Clomipramine—Diarrhoea—Captopril—coronary artery disease	2.28e-05	0.000158	CcSEcCtD
Clomipramine—Dyspnoea—Timolol—coronary artery disease	2.27e-05	0.000157	CcSEcCtD
Clomipramine—Dizziness—Telmisartan—coronary artery disease	2.26e-05	0.000157	CcSEcCtD
Clomipramine—Rash—Pravastatin—coronary artery disease	2.26e-05	0.000157	CcSEcCtD
Clomipramine—Dermatitis—Pravastatin—coronary artery disease	2.26e-05	0.000157	CcSEcCtD
Clomipramine—Decreased appetite—Ramipril—coronary artery disease	2.26e-05	0.000157	CcSEcCtD
Clomipramine—Somnolence—Timolol—coronary artery disease	2.26e-05	0.000157	CcSEcCtD
Clomipramine—Asthenia—Furosemide—coronary artery disease	2.26e-05	0.000156	CcSEcCtD
Clomipramine—Headache—Pravastatin—coronary artery disease	2.25e-05	0.000156	CcSEcCtD
Clomipramine—Anorexia—Lisinopril—coronary artery disease	2.25e-05	0.000156	CcSEcCtD
Clomipramine—Gastrointestinal disorder—Ramipril—coronary artery disease	2.24e-05	0.000156	CcSEcCtD
Clomipramine—Fatigue—Ramipril—coronary artery disease	2.24e-05	0.000155	CcSEcCtD
Clomipramine—Dyspepsia—Timolol—coronary artery disease	2.24e-05	0.000155	CcSEcCtD
Clomipramine—Hypersensitivity—Losartan—coronary artery disease	2.23e-05	0.000155	CcSEcCtD
Clomipramine—Nausea—Valsartan—coronary artery disease	2.23e-05	0.000154	CcSEcCtD
Clomipramine—Pruritus—Furosemide—coronary artery disease	2.22e-05	0.000154	CcSEcCtD
Clomipramine—Constipation—Ramipril—coronary artery disease	2.22e-05	0.000154	CcSEcCtD
Clomipramine—Nausea—Olmesartan—coronary artery disease	2.22e-05	0.000154	CcSEcCtD
Clomipramine—Vomiting—Trandolapril—coronary artery disease	2.22e-05	0.000154	CcSEcCtD
Clomipramine—Diarrhoea—Perindopril—coronary artery disease	2.21e-05	0.000153	CcSEcCtD
Clomipramine—Decreased appetite—Timolol—coronary artery disease	2.21e-05	0.000153	CcSEcCtD
Clomipramine—Vomiting—Enalapril—coronary artery disease	2.21e-05	0.000153	CcSEcCtD
Clomipramine—Hypotension—Lisinopril—coronary artery disease	2.2e-05	0.000153	CcSEcCtD
Clomipramine—Dizziness—Captopril—coronary artery disease	2.2e-05	0.000153	CcSEcCtD
Clomipramine—Rash—Trandolapril—coronary artery disease	2.2e-05	0.000152	CcSEcCtD
Clomipramine—Dermatitis—Trandolapril—coronary artery disease	2.2e-05	0.000152	CcSEcCtD
Clomipramine—Gastrointestinal disorder—Timolol—coronary artery disease	2.19e-05	0.000152	CcSEcCtD
Clomipramine—Fatigue—Timolol—coronary artery disease	2.19e-05	0.000152	CcSEcCtD
Clomipramine—Rash—Enalapril—coronary artery disease	2.19e-05	0.000152	CcSEcCtD
Clomipramine—Dermatitis—Enalapril—coronary artery disease	2.19e-05	0.000152	CcSEcCtD
Clomipramine—Headache—Trandolapril—coronary artery disease	2.18e-05	0.000151	CcSEcCtD
Clomipramine—Vomiting—Telmisartan—coronary artery disease	2.18e-05	0.000151	CcSEcCtD
Clomipramine—Asthenia—Losartan—coronary artery disease	2.18e-05	0.000151	CcSEcCtD
Clomipramine—Headache—Enalapril—coronary artery disease	2.18e-05	0.000151	CcSEcCtD
Clomipramine—Pain—Timolol—coronary artery disease	2.17e-05	0.000151	CcSEcCtD
Clomipramine—Nausea—Niacin—coronary artery disease	2.17e-05	0.00015	CcSEcCtD
Clomipramine—Rash—Telmisartan—coronary artery disease	2.16e-05	0.00015	CcSEcCtD
Clomipramine—Dermatitis—Telmisartan—coronary artery disease	2.16e-05	0.00015	CcSEcCtD
Clomipramine—Diarrhoea—Furosemide—coronary artery disease	2.15e-05	0.000149	CcSEcCtD
Clomipramine—Musculoskeletal discomfort—Lisinopril—coronary artery disease	2.15e-05	0.000149	CcSEcCtD
Clomipramine—Pruritus—Losartan—coronary artery disease	2.15e-05	0.000149	CcSEcCtD
Clomipramine—Headache—Telmisartan—coronary artery disease	2.15e-05	0.000149	CcSEcCtD
Clomipramine—Feeling abnormal—Ramipril—coronary artery disease	2.14e-05	0.000149	CcSEcCtD
Clomipramine—Dizziness—Perindopril—coronary artery disease	2.14e-05	0.000148	CcSEcCtD
Clomipramine—Insomnia—Lisinopril—coronary artery disease	2.13e-05	0.000148	CcSEcCtD
Clomipramine—Nausea—Pravastatin—coronary artery disease	2.13e-05	0.000148	CcSEcCtD
Clomipramine—Gastrointestinal pain—Ramipril—coronary artery disease	2.13e-05	0.000147	CcSEcCtD
Clomipramine—Paraesthesia—Lisinopril—coronary artery disease	2.12e-05	0.000147	CcSEcCtD
Clomipramine—Vomiting—Captopril—coronary artery disease	2.12e-05	0.000147	CcSEcCtD
Clomipramine—Dyspnoea—Lisinopril—coronary artery disease	2.1e-05	0.000146	CcSEcCtD
Clomipramine—Rash—Captopril—coronary artery disease	2.1e-05	0.000146	CcSEcCtD
Clomipramine—Dermatitis—Captopril—coronary artery disease	2.1e-05	0.000145	CcSEcCtD
Clomipramine—Somnolence—Lisinopril—coronary artery disease	2.1e-05	0.000145	CcSEcCtD
Clomipramine—Feeling abnormal—Timolol—coronary artery disease	2.09e-05	0.000145	CcSEcCtD
Clomipramine—Headache—Captopril—coronary artery disease	2.09e-05	0.000145	CcSEcCtD
Clomipramine—Gastrointestinal pain—Timolol—coronary artery disease	2.08e-05	0.000144	CcSEcCtD
Clomipramine—Dizziness—Furosemide—coronary artery disease	2.08e-05	0.000144	CcSEcCtD
Clomipramine—Dyspepsia—Lisinopril—coronary artery disease	2.08e-05	0.000144	CcSEcCtD
Clomipramine—Diarrhoea—Losartan—coronary artery disease	2.07e-05	0.000144	CcSEcCtD
Clomipramine—Nausea—Trandolapril—coronary artery disease	2.07e-05	0.000144	CcSEcCtD
Clomipramine—Urticaria—Ramipril—coronary artery disease	2.07e-05	0.000143	CcSEcCtD
Clomipramine—Nausea—Enalapril—coronary artery disease	2.06e-05	0.000143	CcSEcCtD
Clomipramine—Vomiting—Perindopril—coronary artery disease	2.06e-05	0.000143	CcSEcCtD
Clomipramine—Body temperature increased—Ramipril—coronary artery disease	2.06e-05	0.000143	CcSEcCtD
Clomipramine—Abdominal pain—Ramipril—coronary artery disease	2.06e-05	0.000143	CcSEcCtD
Clomipramine—Decreased appetite—Lisinopril—coronary artery disease	2.05e-05	0.000142	CcSEcCtD
Clomipramine—Chlorpromazine—HTR2A—coronary artery disease	2.05e-05	0.00853	CrCbGaD
Clomipramine—Rash—Perindopril—coronary artery disease	2.04e-05	0.000141	CcSEcCtD
Clomipramine—Imipramine—HTR2A—coronary artery disease	2.04e-05	0.00848	CrCbGaD
Clomipramine—Dermatitis—Perindopril—coronary artery disease	2.04e-05	0.000141	CcSEcCtD
Clomipramine—Gastrointestinal disorder—Lisinopril—coronary artery disease	2.04e-05	0.000141	CcSEcCtD
Clomipramine—Nausea—Telmisartan—coronary artery disease	2.03e-05	0.000141	CcSEcCtD
Clomipramine—Fatigue—Lisinopril—coronary artery disease	2.03e-05	0.000141	CcSEcCtD
Clomipramine—Amitriptyline—HTR2A—coronary artery disease	2.03e-05	0.00843	CrCbGaD
Clomipramine—Headache—Perindopril—coronary artery disease	2.03e-05	0.00014	CcSEcCtD
Clomipramine—Urticaria—Timolol—coronary artery disease	2.02e-05	0.00014	CcSEcCtD
Clomipramine—Constipation—Lisinopril—coronary artery disease	2.02e-05	0.00014	CcSEcCtD
Clomipramine—Pain—Lisinopril—coronary artery disease	2.02e-05	0.00014	CcSEcCtD
Clomipramine—Abdominal pain—Timolol—coronary artery disease	2.01e-05	0.000139	CcSEcCtD
Clomipramine—Body temperature increased—Timolol—coronary artery disease	2.01e-05	0.000139	CcSEcCtD
Clomipramine—Dizziness—Losartan—coronary artery disease	2.01e-05	0.000139	CcSEcCtD
Clomipramine—Vomiting—Furosemide—coronary artery disease	2e-05	0.000139	CcSEcCtD
Clomipramine—Nortriptyline—ALB—coronary artery disease	2e-05	0.00831	CrCbGaD
Clomipramine—Rash—Furosemide—coronary artery disease	1.98e-05	0.000137	CcSEcCtD
Clomipramine—Dermatitis—Furosemide—coronary artery disease	1.98e-05	0.000137	CcSEcCtD
Clomipramine—Nausea—Captopril—coronary artery disease	1.98e-05	0.000137	CcSEcCtD
Clomipramine—Headache—Furosemide—coronary artery disease	1.97e-05	0.000137	CcSEcCtD
Clomipramine—Feeling abnormal—Lisinopril—coronary artery disease	1.94e-05	0.000135	CcSEcCtD
Clomipramine—Gastrointestinal pain—Lisinopril—coronary artery disease	1.93e-05	0.000134	CcSEcCtD
Clomipramine—Vomiting—Losartan—coronary artery disease	1.93e-05	0.000134	CcSEcCtD
Clomipramine—Nausea—Perindopril—coronary artery disease	1.92e-05	0.000133	CcSEcCtD
Clomipramine—Hypersensitivity—Ramipril—coronary artery disease	1.92e-05	0.000133	CcSEcCtD
Clomipramine—Rash—Losartan—coronary artery disease	1.91e-05	0.000133	CcSEcCtD
Clomipramine—Dermatitis—Losartan—coronary artery disease	1.91e-05	0.000132	CcSEcCtD
Clomipramine—Headache—Losartan—coronary artery disease	1.9e-05	0.000132	CcSEcCtD
Clomipramine—Urticaria—Lisinopril—coronary artery disease	1.87e-05	0.00013	CcSEcCtD
Clomipramine—Hypersensitivity—Timolol—coronary artery disease	1.87e-05	0.00013	CcSEcCtD
Clomipramine—Nausea—Furosemide—coronary artery disease	1.87e-05	0.000129	CcSEcCtD
Clomipramine—Asthenia—Ramipril—coronary artery disease	1.87e-05	0.000129	CcSEcCtD
Clomipramine—Abdominal pain—Lisinopril—coronary artery disease	1.86e-05	0.000129	CcSEcCtD
Clomipramine—Body temperature increased—Lisinopril—coronary artery disease	1.86e-05	0.000129	CcSEcCtD
Clomipramine—Pruritus—Ramipril—coronary artery disease	1.84e-05	0.000128	CcSEcCtD
Clomipramine—Asthenia—Timolol—coronary artery disease	1.82e-05	0.000126	CcSEcCtD
Clomipramine—Nausea—Losartan—coronary artery disease	1.8e-05	0.000125	CcSEcCtD
Clomipramine—Pruritus—Timolol—coronary artery disease	1.8e-05	0.000125	CcSEcCtD
Clomipramine—Diarrhoea—Ramipril—coronary artery disease	1.78e-05	0.000123	CcSEcCtD
Clomipramine—Diarrhoea—Timolol—coronary artery disease	1.74e-05	0.000121	CcSEcCtD
Clomipramine—Hypersensitivity—Lisinopril—coronary artery disease	1.74e-05	0.00012	CcSEcCtD
Clomipramine—Dizziness—Ramipril—coronary artery disease	1.72e-05	0.000119	CcSEcCtD
Clomipramine—Asthenia—Lisinopril—coronary artery disease	1.69e-05	0.000117	CcSEcCtD
Clomipramine—Dizziness—Timolol—coronary artery disease	1.68e-05	0.000117	CcSEcCtD
Clomipramine—Pruritus—Lisinopril—coronary artery disease	1.67e-05	0.000116	CcSEcCtD
Clomipramine—Vomiting—Ramipril—coronary artery disease	1.65e-05	0.000115	CcSEcCtD
Clomipramine—Rash—Ramipril—coronary artery disease	1.64e-05	0.000114	CcSEcCtD
Clomipramine—Dermatitis—Ramipril—coronary artery disease	1.64e-05	0.000114	CcSEcCtD
Clomipramine—Headache—Ramipril—coronary artery disease	1.63e-05	0.000113	CcSEcCtD
Clomipramine—Vomiting—Timolol—coronary artery disease	1.62e-05	0.000112	CcSEcCtD
Clomipramine—Diarrhoea—Lisinopril—coronary artery disease	1.61e-05	0.000112	CcSEcCtD
Clomipramine—Rash—Timolol—coronary artery disease	1.6e-05	0.000111	CcSEcCtD
Clomipramine—Dermatitis—Timolol—coronary artery disease	1.6e-05	0.000111	CcSEcCtD
Clomipramine—Headache—Timolol—coronary artery disease	1.59e-05	0.00011	CcSEcCtD
Clomipramine—Dizziness—Lisinopril—coronary artery disease	1.56e-05	0.000108	CcSEcCtD
Clomipramine—Nausea—Ramipril—coronary artery disease	1.54e-05	0.000107	CcSEcCtD
Clomipramine—Nausea—Timolol—coronary artery disease	1.51e-05	0.000105	CcSEcCtD
Clomipramine—Diazepam—ALB—coronary artery disease	1.51e-05	0.00628	CrCbGaD
Clomipramine—Vomiting—Lisinopril—coronary artery disease	1.5e-05	0.000104	CcSEcCtD
Clomipramine—Rash—Lisinopril—coronary artery disease	1.49e-05	0.000103	CcSEcCtD
Clomipramine—Dermatitis—Lisinopril—coronary artery disease	1.49e-05	0.000103	CcSEcCtD
Clomipramine—Headache—Lisinopril—coronary artery disease	1.48e-05	0.000102	CcSEcCtD
Clomipramine—Chlorpromazine—ALB—coronary artery disease	1.4e-05	0.00583	CrCbGaD
Clomipramine—Nausea—Lisinopril—coronary artery disease	1.4e-05	9.71e-05	CcSEcCtD
Clomipramine—Amitriptyline—ALB—coronary artery disease	1.39e-05	0.00577	CrCbGaD
Clomipramine—CYP2D6—Metabolism—GSTP1—coronary artery disease	1.52e-06	1.87e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—GSTM1—coronary artery disease	1.51e-06	1.87e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—POMC—coronary artery disease	1.51e-06	1.86e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—HIF1A—coronary artery disease	1.51e-06	1.86e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—NFKBIA—coronary artery disease	1.51e-06	1.86e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—ALDH2—coronary artery disease	1.5e-06	1.85e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—PPARGC1A—coronary artery disease	1.5e-06	1.85e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—AGT—coronary artery disease	1.5e-06	1.85e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—HMOX1—coronary artery disease	1.49e-06	1.84e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Hemostasis—AKT1—coronary artery disease	1.49e-06	1.84e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	1.49e-06	1.84e-05	CbGpPWpGaD
Clomipramine—ALB—Metabolism—MTHFR—coronary artery disease	1.49e-06	1.84e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—LPL—coronary artery disease	1.49e-06	1.83e-05	CbGpPWpGaD
Clomipramine—HTR2B—GPCR downstream signaling—AKT1—coronary artery disease	1.48e-06	1.83e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—GSTM1—coronary artery disease	1.48e-06	1.82e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—ABCA1—coronary artery disease	1.48e-06	1.82e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—CAT—coronary artery disease	1.47e-06	1.82e-05	CbGpPWpGaD
Clomipramine—HTR6—Signaling by GPCR—AKT1—coronary artery disease	1.47e-06	1.82e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—APOE—coronary artery disease	1.47e-06	1.81e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—LEP—coronary artery disease	1.47e-06	1.81e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—CASP3—coronary artery disease	1.47e-06	1.81e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—HBA1—coronary artery disease	1.46e-06	1.81e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—LIPC—coronary artery disease	1.46e-06	1.81e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—CYP2C19—coronary artery disease	1.46e-06	1.81e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—PIK3C2A—coronary artery disease	1.46e-06	1.81e-05	CbGpPWpGaD
Clomipramine—HTR2C—GPCR downstream signaling—PIK3CA—coronary artery disease	1.46e-06	1.8e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—SERPINE1—coronary artery disease	1.46e-06	1.8e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—KIT—coronary artery disease	1.46e-06	1.8e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling by GPCR—IL6—coronary artery disease	1.46e-06	1.8e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—APOC3—coronary artery disease	1.46e-06	1.79e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—APOA1—coronary artery disease	1.45e-06	1.79e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—LPL—coronary artery disease	1.45e-06	1.79e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—GPX1—coronary artery disease	1.45e-06	1.79e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—LDLR—coronary artery disease	1.45e-06	1.78e-05	CbGpPWpGaD
Clomipramine—ALB—Hemostasis—PIK3CA—coronary artery disease	1.44e-06	1.78e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—KDR—coronary artery disease	1.44e-06	1.78e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—APOB—coronary artery disease	1.43e-06	1.76e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—MAPK14—coronary artery disease	1.43e-06	1.76e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—SLC9A1—coronary artery disease	1.43e-06	1.76e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—GSTT1—coronary artery disease	1.43e-06	1.76e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—GOT1—coronary artery disease	1.43e-06	1.76e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—GGT1—coronary artery disease	1.43e-06	1.76e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—CCND1—coronary artery disease	1.43e-06	1.76e-05	CbGpPWpGaD
Clomipramine—ALB—Metabolism—AGT—coronary artery disease	1.42e-06	1.75e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—GPX1—coronary artery disease	1.42e-06	1.74e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—FGF2—coronary artery disease	1.41e-06	1.74e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—GCLC—coronary artery disease	1.41e-06	1.74e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—CETP—coronary artery disease	1.41e-06	1.74e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—CD36—coronary artery disease	1.41e-06	1.74e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—ESR1—coronary artery disease	1.4e-06	1.73e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—GSK3B—coronary artery disease	1.4e-06	1.73e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—SDC1—coronary artery disease	1.4e-06	1.72e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—PPP2CA—coronary artery disease	1.39e-06	1.72e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—NOS3—coronary artery disease	1.39e-06	1.72e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—GSTM1—coronary artery disease	1.39e-06	1.72e-05	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—PIK3CA—coronary artery disease	1.39e-06	1.71e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—POMC—coronary artery disease	1.39e-06	1.71e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—CREB1—coronary artery disease	1.39e-06	1.71e-05	CbGpPWpGaD
Clomipramine—ALB—Metabolism—APOE—coronary artery disease	1.39e-06	1.71e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—MMP9—coronary artery disease	1.39e-06	1.71e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—FN1—coronary artery disease	1.39e-06	1.71e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—F2—coronary artery disease	1.39e-06	1.71e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—IL6ST—coronary artery disease	1.38e-06	1.7e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—CD36—coronary artery disease	1.38e-06	1.7e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—ALB—coronary artery disease	1.38e-06	1.7e-05	CbGpPWpGaD
Clomipramine—ALB—Metabolism—APOA1—coronary artery disease	1.37e-06	1.69e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—NFKBIA—coronary artery disease	1.37e-06	1.69e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—LPL—coronary artery disease	1.37e-06	1.69e-05	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—VEGFA—coronary artery disease	1.36e-06	1.68e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—PPP2CA—coronary artery disease	1.36e-06	1.68e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—CCL2—coronary artery disease	1.36e-06	1.67e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—JAK2—coronary artery disease	1.36e-06	1.67e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—IL6R—coronary artery disease	1.35e-06	1.67e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling by GPCR—AKT1—coronary artery disease	1.34e-06	1.66e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—MTHFR—coronary artery disease	1.34e-06	1.65e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—IGF1—coronary artery disease	1.34e-06	1.65e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—GPX1—coronary artery disease	1.33e-06	1.64e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—MAPK1—coronary artery disease	1.33e-06	1.64e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—PIK3CA—coronary artery disease	1.33e-06	1.64e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—KIT—coronary artery disease	1.33e-06	1.64e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—PSMB5—coronary artery disease	1.32e-06	1.63e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—PSMA6—coronary artery disease	1.32e-06	1.63e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—NOS3—coronary artery disease	1.32e-06	1.62e-05	CbGpPWpGaD
Clomipramine—ALB—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	1.31e-06	1.62e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—MTHFR—coronary artery disease	1.31e-06	1.61e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—CD36—coronary artery disease	1.3e-06	1.6e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—CTGF—coronary artery disease	1.29e-06	1.59e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—GSTP1—coronary artery disease	1.28e-06	1.58e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—PPP2CA—coronary artery disease	1.28e-06	1.58e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—HMGCR—coronary artery disease	1.28e-06	1.58e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—GOT2—coronary artery disease	1.28e-06	1.58e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—GSK3B—coronary artery disease	1.27e-06	1.57e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—PPARGC1A—coronary artery disease	1.27e-06	1.57e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—AGT—coronary artery disease	1.27e-06	1.57e-05	CbGpPWpGaD
Clomipramine—HTR2A—GPCR downstream signaling—PIK3CA—coronary artery disease	1.27e-06	1.57e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—SERPINE1—coronary artery disease	1.27e-06	1.56e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—HMOX1—coronary artery disease	1.27e-06	1.56e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—POMC—coronary artery disease	1.26e-06	1.56e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—CREB1—coronary artery disease	1.26e-06	1.56e-05	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—TGFB1—coronary artery disease	1.25e-06	1.54e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—CAT—coronary artery disease	1.25e-06	1.54e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—APOE—coronary artery disease	1.25e-06	1.54e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—VEGFA—coronary artery disease	1.25e-06	1.53e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—AGT—coronary artery disease	1.24e-06	1.53e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—CXCL8—coronary artery disease	1.24e-06	1.52e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—CCL2—coronary artery disease	1.24e-06	1.52e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—IL6R—coronary artery disease	1.23e-06	1.52e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—APOA1—coronary artery disease	1.23e-06	1.52e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—MTHFR—coronary artery disease	1.23e-06	1.52e-05	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—IL6—coronary artery disease	1.23e-06	1.52e-05	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—MAPK1—coronary artery disease	1.23e-06	1.51e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—FGF2—coronary artery disease	1.23e-06	1.51e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—APOE—coronary artery disease	1.22e-06	1.5e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—IGF1—coronary artery disease	1.21e-06	1.5e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—APOB—coronary artery disease	1.21e-06	1.5e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—NOS3—coronary artery disease	1.21e-06	1.49e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—MAPK1—coronary artery disease	1.21e-06	1.49e-05	CbGpPWpGaD
Clomipramine—ALB—Metabolism—PPARG—coronary artery disease	1.21e-06	1.49e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—PTGS2—coronary artery disease	1.2e-06	1.49e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—APOA1—coronary artery disease	1.2e-06	1.48e-05	CbGpPWpGaD
Clomipramine—HTR2C—GPCR downstream signaling—AKT1—coronary artery disease	1.19e-06	1.47e-05	CbGpPWpGaD
Clomipramine—ALB—Metabolism—POMC—coronary artery disease	1.19e-06	1.47e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—CASP3—coronary artery disease	1.18e-06	1.46e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—GSTM1—coronary artery disease	1.18e-06	1.45e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	1.18e-06	1.45e-05	CbGpPWpGaD
Clomipramine—ALB—Hemostasis—AKT1—coronary artery disease	1.18e-06	1.45e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—JAK2—coronary artery disease	1.18e-06	1.45e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—IL6—coronary artery disease	1.18e-06	1.45e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—PLCB1—coronary artery disease	1.17e-06	1.45e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—AGT—coronary artery disease	1.17e-06	1.44e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—LPL—coronary artery disease	1.16e-06	1.43e-05	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR downstream signaling—PIK3CA—coronary artery disease	1.16e-06	1.42e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—SERPINE1—coronary artery disease	1.15e-06	1.42e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—PIK3CA—coronary artery disease	1.15e-06	1.42e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—CCND1—coronary artery disease	1.15e-06	1.42e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—APOE—coronary artery disease	1.15e-06	1.41e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—TGFB1—coronary artery disease	1.14e-06	1.41e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—ABCA1—coronary artery disease	1.14e-06	1.4e-05	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—AKT1—coronary artery disease	1.13e-06	1.4e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—APOA1—coronary artery disease	1.13e-06	1.4e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—GPX1—coronary artery disease	1.13e-06	1.39e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—MAPK1—coronary artery disease	1.12e-06	1.38e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—MMP9—coronary artery disease	1.12e-06	1.38e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—FGF2—coronary artery disease	1.12e-06	1.38e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—GGT1—coronary artery disease	1.1e-06	1.36e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—GOT1—coronary artery disease	1.1e-06	1.36e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—NOS3—coronary artery disease	1.1e-06	1.36e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—CD36—coronary artery disease	1.1e-06	1.36e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—PPP2CA—coronary artery disease	1.09e-06	1.34e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—PPARG—coronary artery disease	1.09e-06	1.34e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—AKT1—coronary artery disease	1.08e-06	1.34e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—CXCL8—coronary artery disease	1.07e-06	1.32e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—JAK2—coronary artery disease	1.07e-06	1.32e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—POMC—coronary artery disease	1.07e-06	1.32e-05	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—PIK3CA—coronary artery disease	1.07e-06	1.31e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—PPARG—coronary artery disease	1.06e-06	1.31e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—PIK3CA—coronary artery disease	1.05e-06	1.29e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—POMC—coronary artery disease	1.04e-06	1.29e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—MTHFR—coronary artery disease	1.04e-06	1.29e-05	CbGpPWpGaD
Clomipramine—ALB—Metabolism—NOS3—coronary artery disease	1.04e-06	1.28e-05	CbGpPWpGaD
Clomipramine—HTR2A—GPCR downstream signaling—AKT1—coronary artery disease	1.04e-06	1.28e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—CASP3—coronary artery disease	1.03e-06	1.27e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—IL6—coronary artery disease	1.02e-06	1.26e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—VEGFA—coronary artery disease	1e-06	1.24e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—CCND1—coronary artery disease	1e-06	1.23e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—PPARG—coronary artery disease	9.98e-07	1.23e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—GSTP1—coronary artery disease	9.91e-07	1.22e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—AGT—coronary artery disease	9.91e-07	1.22e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—POMC—coronary artery disease	9.84e-07	1.21e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—PPARGC1A—coronary artery disease	9.82e-07	1.21e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—HMOX1—coronary artery disease	9.77e-07	1.2e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—CXCL8—coronary artery disease	9.77e-07	1.2e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—ALB—coronary artery disease	9.76e-07	1.2e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—PIK3CA—coronary artery disease	9.72e-07	1.2e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—MMP9—coronary artery disease	9.71e-07	1.2e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—APOE—coronary artery disease	9.71e-07	1.2e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—CAT—coronary artery disease	9.64e-07	1.19e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—APOA1—coronary artery disease	9.6e-07	1.18e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—ALB—coronary artery disease	9.52e-07	1.17e-05	CbGpPWpGaD
Clomipramine—ALB—Metabolism—PTGS2—coronary artery disease	9.51e-07	1.17e-05	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR downstream signaling—AKT1—coronary artery disease	9.44e-07	1.16e-05	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—IL6—coronary artery disease	9.43e-07	1.16e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—AKT1—coronary artery disease	9.42e-07	1.16e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—APOB—coronary artery disease	9.36e-07	1.15e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—CASP3—coronary artery disease	9.35e-07	1.15e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—NOS3—coronary artery disease	9.33e-07	1.15e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—IL6—coronary artery disease	9.29e-07	1.15e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—TGFB1—coronary artery disease	9.22e-07	1.14e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	9.19e-07	1.13e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—NOS3—coronary artery disease	9.11e-07	1.12e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—GSTM1—coronary artery disease	9.1e-07	1.12e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—CCND1—coronary artery disease	9.1e-07	1.12e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—MAPK1—coronary artery disease	9.04e-07	1.11e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—ALB—coronary artery disease	8.97e-07	1.11e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—LPL—coronary artery disease	8.94e-07	1.1e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—MMP9—coronary artery disease	8.84e-07	1.09e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—VEGFA—coronary artery disease	8.72e-07	1.08e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—GPX1—coronary artery disease	8.72e-07	1.07e-05	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—AKT1—coronary artery disease	8.7e-07	1.07e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—IL6—coronary artery disease	8.61e-07	1.06e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—NOS3—coronary artery disease	8.58e-07	1.06e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—AKT1—coronary artery disease	8.57e-07	1.06e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—PTGS2—coronary artery disease	8.54e-07	1.05e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—CD36—coronary artery disease	8.49e-07	1.05e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—PPARG—coronary artery disease	8.45e-07	1.04e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—PPP2CA—coronary artery disease	8.39e-07	1.03e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—POMC—coronary artery disease	8.34e-07	1.03e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—PTGS2—coronary artery disease	8.33e-07	1.03e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—MTHFR—coronary artery disease	8.05e-07	9.92e-06	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—TGFB1—coronary artery disease	8.01e-07	9.87e-06	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—AKT1—coronary artery disease	7.94e-07	9.79e-06	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—VEGFA—coronary artery disease	7.94e-07	9.78e-06	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—MAPK1—coronary artery disease	7.85e-07	9.68e-06	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—PTGS2—coronary artery disease	7.85e-07	9.68e-06	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—PIK3CA—coronary artery disease	7.85e-07	9.67e-06	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—AGT—coronary artery disease	7.65e-07	9.43e-06	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—ALB—coronary artery disease	7.6e-07	9.37e-06	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—APOE—coronary artery disease	7.49e-07	9.24e-06	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—PIK3CA—coronary artery disease	7.41e-07	9.14e-06	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—APOA1—coronary artery disease	7.41e-07	9.13e-06	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—TGFB1—coronary artery disease	7.28e-07	8.98e-06	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—NOS3—coronary artery disease	7.27e-07	8.97e-06	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—MAPK1—coronary artery disease	7.14e-07	8.81e-06	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—IL6—coronary artery disease	6.95e-07	8.56e-06	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—PIK3CA—coronary artery disease	6.81e-07	8.4e-06	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—PTGS2—coronary artery disease	6.65e-07	8.2e-06	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—PPARG—coronary artery disease	6.53e-07	8.04e-06	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—POMC—coronary artery disease	6.44e-07	7.93e-06	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—AKT1—coronary artery disease	6.41e-07	7.9e-06	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—PIK3CA—coronary artery disease	6.2e-07	7.64e-06	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—AKT1—coronary artery disease	6.06e-07	7.47e-06	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—IL6—coronary artery disease	6.03e-07	7.44e-06	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—ALB—coronary artery disease	5.87e-07	7.23e-06	CbGpPWpGaD
Clomipramine—ALB—Metabolism—PIK3CA—coronary artery disease	5.85e-07	7.21e-06	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—NOS3—coronary artery disease	5.61e-07	6.92e-06	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—AKT1—coronary artery disease	5.57e-07	6.86e-06	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—IL6—coronary artery disease	5.49e-07	6.77e-06	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—PIK3CA—coronary artery disease	5.25e-07	6.47e-06	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—PTGS2—coronary artery disease	5.13e-07	6.33e-06	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—PIK3CA—coronary artery disease	5.13e-07	6.32e-06	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—AKT1—coronary artery disease	5.06e-07	6.24e-06	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—PIK3CA—coronary artery disease	4.83e-07	5.95e-06	CbGpPWpGaD
Clomipramine—ALB—Metabolism—AKT1—coronary artery disease	4.78e-07	5.89e-06	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—AKT1—coronary artery disease	4.29e-07	5.29e-06	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—AKT1—coronary artery disease	4.19e-07	5.16e-06	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—PIK3CA—coronary artery disease	4.09e-07	5.04e-06	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—AKT1—coronary artery disease	3.95e-07	4.86e-06	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—AKT1—coronary artery disease	3.34e-07	4.12e-06	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—PIK3CA—coronary artery disease	3.16e-07	3.89e-06	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—AKT1—coronary artery disease	2.58e-07	3.18e-06	CbGpPWpGaD
